EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world study

Jeannie M'Baloula, David Tougeron, Alice Boilève, Elodie Jeanbert, Rosine Guimbaud, Meher Ben Abdelghani, Alice Durand, Anthony Turpin, Stanislas Quesada, Jean Frédéric Blanc, Pascal Artru, Clémence Toullec und 11 weitere

European Journal of Cancer · 2024

DOI: 10.1016/j.ejca.2024.115051 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Jeannie M'Baloula und 22 weiteren Autor:innen. Beteiligte Einrichtung: University of Lorraine, Department of Hepato-Gastroenterology and digestive oncology, Nancy University Hospital, Nancy, France. Hauptthemen laut MEDLINE: Phthalazines, Pancreatic Neoplasms, Piperazines. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhthalazinesPancreatic NeoplasmsPiperazinesHumansFemaleMaleRetrospective StudiesMiddle AgedAgedCarcinoma, Pancreatic DuctalPoly(ADP-ribose) Polymerase InhibitorsFranceAdultMaintenance ChemotherapyAged, 80 and overBRCA2 Protein

Stichwörter der Autor:innen

(MeSH terms)BRCAHereditary neoplastic syndromesHomologous recombination deficiencyPARP inhibitorPancreatic ductal adenocarcinoma

Substanzen

olaparibPhthalazinesPiperazinesPoly(ADP-ribose) Polymerase InhibitorsBRCA2 ProteinBRCA2 protein, human

Autor:innen und Institutionen

  • University of Lorraine, Department of Hepato-Gastroenterology and digestive oncology, Nancy University Hospital, Nancy, France.
  • Department of Hepatology and Gastroenterology, Poitiers University Hospital, Poitiers, France.
  • Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
  • DRCI, MPI Department, Methodology, Data Management and Statistics Unit, Nancy University Hospital, Nancy, France.
  • Digestive Medical Oncology, Toulouse University Hospital, Toulouse, France.
  • Medical Oncology Department, ICANS, Strasbourg, France.

Zitieren

APA

M'Baloula, J., Tougeron, D., Boilève, A., Jeanbert, E., Guimbaud, R., Ben Abdelghani, M., Durand, A., Turpin, A., Quesada, S., Blanc, J. F., Artru, P., Toullec, C., Trouilloud, I., Pellat, A., Touchefeu, Y., Pinot, J., Caroli-Bosc, F. X., Taïeb, J., Doat, S., …, & Muller, M. (2024). Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world study. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.115051

Vancouver

M'Baloula J, Tougeron D, Boilève A, Jeanbert E, Guimbaud R, Ben Abdelghani M, et al. Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world study. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2024.115051

BibTeX
@article{MBaloula2024,
  author = {M'Baloula, Jeannie and Tougeron, David and Boilève, Alice and Jeanbert, Elodie and Guimbaud, Rosine and Ben Abdelghani, Meher and Durand, Alice and Turpin, Anthony and Quesada, Stanislas and Blanc, Jean Frédéric and Artru, Pascal and Toullec, Clémence and Trouilloud, Isabelle and Pellat, Anna and Touchefeu, Yann and Pinot, Julien and Caroli-Bosc, François-Xavier and Taïeb, Julien and Doat, Solène and Bouché, Olivier and Védie, Anne Laure and de Mestier, Louis and Muller, Marie},
  title = {Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world study},
  journal = {European Journal of Cancer},
  year = {2024},
  doi = {10.1016/j.ejca.2024.115051}
}
Kostenlos starten →